REX-4019

N/A

Report date: 2023/09/18 14:10:37
NME

Base Information

Drug NameREX-4019
Drug Alias NameREX-4019
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal transducer and activator of transcription 3 inhibitors
TargetsSignal transducer and activator of transcription 3
Therapy Area/IndicationsEncephalomyelitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRecludix Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesRecludix Pharma Inc
Inactive CompaniesN/A
Active IndicationsEncephalomyelitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A